The following four treatments, including the links and resources, are from Lady Liberty’s show notes which she has read numerous times on the Morning Commute radio show. If you contract the CCP virus, discuss these alternatives with your health care provider. The following treatments have reportedly reduced or eliminated the need for hospitalization and/or intensive care. Some have reported 100% recovery rates with no Covid-19 related deaths.
The critics argue that these treatments are too new and untested to trust our lives with, while at the same time
advocating for vaccines which are… (drum roll).. too new and untested to trust our lives with.
We stand firmly by our convictions that that the following treatments (and others not mentioned here) preclude
the necessity for mandatory vaccines.
We strongly believe that forcing a vaccine on the world’s population is by far a greater danger than the Covid-19
virus (aka. CCP — Communist Chinese Party virus).
-JJS and Lady Liberty (Radio Free Redoubt’s The Morning Commute)
TREATMENT 1: Hydroxycholoroquine, Azithromycin, and Zinc
April 20, 2020 — New American Magazine — New York School of Medicine
Dr. Vladimir Zelenko reported positive test results with the following treatments.
- Hydroxychloroquine 200mg
- Azithromycin 500mg
- Zinc sulfate 220 mg
Additional information at:
TREATMENT 2: Budesonide nasal inhalant nebulizer and zinc
6/19/2020 — MSN — Dr. Richard Bartlett
West Texas doctor claims to have “silver bullet” for COVID-19
“The treatment plan is inhaled, generic budesonide,” Bartlett said. “Using some generic antibiotics to protect from a
secondary bacterial infection. Using zinc, which interferes with virus replication. It’s common sense. It’s intuitive.”
Budesonide is a steroid, that can be inhaled directly to the lungs using a nebulizer.
Bartlett said he treats people as soon as they show symptoms.
“Early treatment is better with this disease,” he said. “And I’m having a 100% survival rate. I don’t even know how
many I’ve treated…dozens. I have 14 that I’m treating right now.”
Bartlett said that patients tell him they feel immediate relief.
TREATMENT 3: Combination of Favipiravir and Remdesivir
Aug 20, 2020 Ken Watts IP News Opinion Editorial
Referencing a letter from a professor of pharmacy at the University of Toronto, to his family —
“We did not have drugs to fight the corona virus in February 2020. We were only threatening the complications
caused by it… hypoxia. Hence most patients became severely infected. Now we have 2 important medicines
FAVIPIRAVIR & REMDESIVIR. These are ANTIVIRALS that can kill the corona virus. By using these two
medicines we can prevent patients from becoming severely infected and therefore cure them BEFORE THEY
GO TO HYPOXIA. This knowledge we have in JUNE 2020… Not in February 2020.”
Additional research supporting this combination:
Modeling the use of favipiravir and remdesivir to treat …
If the effect of delayed initiation of treatment is modelled, the authors found that the survival rates are
60% for favipiravir and 100% for remdesivir when treatment is initiated within 3-4 days post-infection. Therefore both favipiravir and remdesivir could be efficacious for treating Ebolavirus disease
Now, they’re primarily using remdesivir, an antiviral drug that appears to help COVID-19 patients
recover more quickly
TREATMENT 4: Ivermectin
12 May 2020 — Epoch Times — University of Kentucky
Scientists at the University of Kentucky’s College of Medicine said they’ll investigate the effectiveness of
azithromycin, ivermectin, and camostat mesylate—drugs that could inhibit the replication of SARS-CoV-2,
the CCP virus.
The trial is the first in the United States to examine ivermectin, a medicine used to treat parasites, in humans
with COVID-19. Ivermectin killed COVID-19 in the lab, researchers said last month.
Azithromycin is a common antibiotic, and camostat mesylate is an enzyme inhibitor.
The three drugs will be tested either as standalone therapies or in combination with hydroxychloroquine, a
drug traditionally used against malaria that’s been widely deployed in hospitals to treat COVID-19 patients.